TG4001

· Transgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TG4001, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers [Phase 1, Phase 2]